Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,901 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,901 in last 12 months

Showing 10411060 of 13,591 recalls

DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1%...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL Recalled by Imprimis NJOF, LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Golden State Medical Supply Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Golden State Medical Supply...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets Recalled by Glenmark...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets Recalled by Glenmark...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· American Regent, Inc.

Recalled Item: Vasopressin Injection Recalled by American Regent, Inc. Due to Subpotent...

The Issue: Subpotent product in addition to having out-of-specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back label states Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back Label states Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 8, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Cefdinir for Oral Suspension USP Recalled by Lupin Pharmaceuticals Inc. Due...

The Issue: Defective container: lack of seal integrity.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund